Latest Insider Transactions at Roivant Sciences Ltd. (ROIV)
This section provides a real-time view of insider transactions for Roivant Sciences Ltd. (ROIV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Roivant Sciences Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Roivant Sciences Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,653
-0.41%
|
$18,183
$11.39 P/Share
|
|
Jun 25
2025
|
Qvt Financial LP |
SELL
Other acquisition or disposition
|
Indirect |
36,756,758
-66.47%
|
-
|
|
Jun 25
2025
|
Keith S Manchester |
SELL
Other acquisition or disposition
|
Indirect |
17,389,525
-49.71%
|
-
|
|
Jun 25
2025
|
Daniel Allen Gold |
SELL
Other acquisition or disposition
|
Indirect |
36,756,758
-66.47%
|
-
|
|
Jun 20
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
100,000
-6.4%
|
$1,100,000
$11.45 P/Share
|
|
Jun 20
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+6.02%
|
$300,000
$3.85 P/Share
|
|
Jun 20
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,503
-0.38%
|
$16,533
$11.45 P/Share
|
|
Jun 20
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
577,007
-1.52%
|
$6,347,077
$11.46 P/Share
|
|
Jun 18
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
565,266
-1.47%
|
$6,217,926
$11.45 P/Share
|
|
Jun 06
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,800
-0.52%
|
$2,208,800
$11.19 P/Share
|
|
Jun 04
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
547,430
-1.4%
|
$6,021,730
$11.34 P/Share
|
|
Jun 03
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
566,278
-27.92%
|
$6,229,058
$11.22 P/Share
|
|
Jun 03
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
785,026
+27.9%
|
$2,355,078
$3.85 P/Share
|
|
Jun 02
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
433,722
-25.86%
|
$4,770,942
$11.07 P/Share
|
|
Jun 02
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
600,000
+26.35%
|
$1,800,000
$3.85 P/Share
|
|
May 28
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,653
-0.41%
|
$16,530
$10.62 P/Share
|
|
May 20
2025
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.06%
|
$120,395
$11.04 P/Share
|
|
May 20
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
100,000
-8.49%
|
$1,000,000
$10.95 P/Share
|
|
May 20
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+7.83%
|
$300,000
$3.85 P/Share
|
|
May 20
2025
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
39,148
-3.51%
|
$430,628
$11.04 P/Share
|
|
May 20
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,487
-0.86%
|
$38,357
$11.04 P/Share
|
|
May 07
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
625,000
-1.57%
|
$6,875,000
$11.18 P/Share
|
|
May 06
2025
|
Vivek Ramaswamy > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
273,959
-0.68%
|
$3,013,549
$11.47 P/Share
|
|
Apr 28
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,653
-0.41%
|
$18,183
$11.19 P/Share
|
|
Apr 21
2025
|
Richard Pulik CFO |
BUY
Grant, award, or other acquisition
|
Direct |
141,464
+25.78%
|
-
|
|
Apr 21
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
100,000
-8.22%
|
$1,000,000
$10.22 P/Share
|
|
Apr 21
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+7.6%
|
$300,000
$3.85 P/Share
|
|
Apr 20
2025
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.06%
|
$109,450
$10.15 P/Share
|
|
Apr 20
2025
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.97%
|
$109,450
$10.15 P/Share
|
|
Apr 17
2025
|
Ilan Oren |
SELL
Payment of exercise price or tax liability
|
Direct |
64
-0.06%
|
$640
$10.15 P/Share
|
|
Apr 17
2025
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
2,635
+2.5%
|
-
|
|
Apr 17
2025
|
James C Momtazee |
SELL
Payment of exercise price or tax liability
|
Direct |
276
-0.29%
|
$2,760
$10.15 P/Share
|
|
Apr 17
2025
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
1,379
+1.42%
|
-
|
|
Apr 17
2025
|
Epperly Melissa B, |
BUY
Grant, award, or other acquisition
|
Direct |
1,847
+4.27%
|
-
|
|
Mar 28
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,653
-0.62%
|
$16,530
$10.38 P/Share
|
|
Mar 24
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
434,478
-27.82%
|
$4,344,780
$10.82 P/Share
|
|
Mar 24
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
602,311
+27.83%
|
$1,806,933
$3.85 P/Share
|
|
Mar 20
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
315,522
-24.75%
|
$3,470,742
$11.06 P/Share
|
|
Mar 20
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
400,000
+23.88%
|
$1,200,000
$3.85 P/Share
|
|
Mar 20
2025
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-1.24%
|
$109,450
$10.97 P/Share
|
|
Mar 20
2025
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.06%
|
$109,450
$10.97 P/Share
|
|
Mar 20
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,504
-0.56%
|
$15,040
$10.97 P/Share
|
|
Mar 20
2025
|
Jennifer Humes Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112,255
+50.0%
|
-
|
|
Feb 28
2025
|
Richard Pulik CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,635
-0.6%
|
$16,350
$10.74 P/Share
|
|
Feb 20
2025
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-1.22%
|
$109,450
$10.72 P/Share
|
|
Feb 20
2025
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
100,000
-10.03%
|
$1,000,000
$10.65 P/Share
|
|
Feb 20
2025
|
Eric Venker President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+9.12%
|
$300,000
$3.85 P/Share
|
|
Feb 20
2025
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,945
-0.06%
|
$109,450
$10.72 P/Share
|
|
Feb 20
2025
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
958
-0.59%
|
$9,580
$10.72 P/Share
|
|
Feb 13
2025
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
227,500
-58.22%
|
$2,275,000
$10.43 P/Share
|